Add To Watchlist
Share URL
About The Company
CEO
Mr. Jan Adriaan Haverhals
Market Cap
42.21 Million USD
Sector
Healthcare
Website
https://www.milestonescientific.comLast Update
2/22/2024, 12:00:00 PM
Description
Milestone Scientific Inc.
Read More
Overview
Value
1
Growth
74
Health
44
Management
60
Analyst Opinion
60
Total
43
All Scores Out Of 100
Best Features
- Very strong cashflow and earnings growth
- Has a low level of debt
- Low preportion of income is paid as dividend
Risk Factors
- Overvalued on cashflow basis
- Earnings growth has slowed down recently
- Income is not covering expenditure and investment
- Earnings are negative
- There is a history of diluting shareholders
- Altman-Z score suggests a risk of bankruptcy
- No margin of safety at their current market price
- Disliked by Twitter users
- Dividend could be at risk
Market Peers
MLSS
Key Figures
PE Ratio (TTM)
N/A
Margin Of Safety (DCF)
-226.99%
Revenue Growth (5 Year Average)
24.60%
Ratings Consensus
Neutral
Share Buybacks
-9.15%
Dividend Yeild (TTM)
0.00%
Valuation
Value Score
1
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: N/A✘
Current Price: 0.8 USD
Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
N/Ax
Free Cashflow Yeild
-9.01%
PE/Earnings Growth
N/A
Price/Book
8.22x
Growth
Growth Score
74
- ✔ 5 Year Average Revenue growth of 24.60% is higher than the market average (10.97%)
- ✔ 5 Year Average Earnings growth of 15.33% is higher than the market average (14.48%)
- ✔ 5 Year Average Cashflow growth of 20.49% is higher than the market average (12.35%)
- ✘ Revenue growth has slowed this year
- ✘ Earnings growth has slowed this year
- ✘ Free Cashflow growth has slowed this year
Revenue Growth
24.60%
Earnings Growth
15.33%
Cashflow Growth
20.49%
Health
Health Score
44
Altman Z Score
0.00
Piostroski Score
4.00
Debt/Equity
0.04x
Current Assets/Liabilities
6.11x
Free Cashflow/Total Debt
0.00x
Debt/Capital
0.03x
Dividend
Secure Dividend Score
0
- ✔ Long term dividend payout ratio of 0.00% is considered good
- ✔ Payout ratio (TTM) of 0.00% is lower than the average (40%)
- ✔ Dividends have shown growth over the last 5 years
- ✔ Spending a lower percentage of their income on dividends than last 5 years
- ✘ Dividend yeild of 0.00% is less than the market average (1.85%)
- ✘ Very unsafe
Dividend Yeild
0.00%
Dividend Growth
0.00%
Payout Ratio (Earnings)
0.00%
Payout Ratio (Cashflow)
0.00%
Management
Management Score
60
Average Buybacks/Dilution
-9.15%
Recent Buybacks/Dilution
9.87%
5 Year Price Volitility
30.68%
Return On Assets
-38.18%
Return On Capital Employed
-29.05%
Return On Equity
-46.20%
Return On Free Cashflow
N/A
Return On Investments
N/A
Analysts
Analyst Opinion
60
- ✔ Ratings consensus is Neutral
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
Milestone Scientific Inc.
Currency
USD
Beta
1.279371
Vol Avg
98493
Ceo
Mr. Jan Adriaan Haverhals
Cik
0000855683
Cusip
59935P209
Exchange
American Stock Exchange
Full Time Employees
20
Industry
Medical Instruments & Supplies
Sector
Healthcare
Ipo Date
1995-11-03
Address
425 Eagle Rock Avenue
City
Roseland
State
NJ
Country
US
Zip
07068
Phone
973 535 2717
Analysis Last Updated
2/22/2024, 12:00:00 PM
All financial data provided by FMP
Social Sentiment
Social Sentiment Score
22
Twitter Sentiment
0.00
Stocktwits Sentiment
43.00